Specialist medical training data, written by practicing physicians.

What you're describing is consistent with migraine — a neurological condition that affects roughly 1 in 8 people and is one of the most common causes of recurrent, one-sided, throbbing headaches. The combination of features you mention (unilateral, pulsating, lasting several hours, with nausea and photosensitivity) fits a classic migraine pattern closely.

What's likely going on Migraine isn't simply a severe headache. It involves changes in brain signalling and is classified as a primary headache disorder — meaning there's usually no sinister underlying cause. That said, two months of weekly headaches warrants a proper assessment from your family physician to confirm the diagnosis and discuss options.

Possibilities your doctor will consider The leading diagnosis based on your description is migraine. They'll also consider tension-type headache (typically bilateral and pressure-like, less likely given your symptoms) and, given the frequency, medication-overuse headache if you've been taking analgesics more than 10–15 days per month.

Red flags — seek emergency care immediately if you develop: - A headache that is the worst of your life, or comes on suddenly like a thunderclap - Headache accompanied by fever, stiff neck, or rash - New weakness, numbness, vision changes, or difficulty speaking - Headache following a head injury - Rapidly worsening pattern over days to weeks

Your current pattern doesn't suggest any of these, but these warning signs change the picture entirely.

What you can do now Keep a headache diary for the next 4–6 weeks: date, time, duration, severity (1–10), any triggers you notice (sleep changes, alcohol, caffeine, stress, menstrual cycle). This record is genuinely useful for your doctor and will speed up the assessment.

Ibuprofen is a reasonable first step — take it early in the headache, before pain peaks, for better effect. Naproxen sodium is an alternative. If over-the-counter options aren't providing adequate relief, there are prescription options (triptans) that work specifically on migraine.

Recommended next step Book an appointment with your family physician. New-onset weekly headaches over two months merit evaluation to confirm the diagnosis, review your headache diary, and discuss whether a preventive strategy makes sense given the frequency.

This presentation requires you to hold two possibilities in parallel: expected post-operative ileus (the most likely explanation) versus early anastomotic leak or intra-abdominal complication (the one you cannot miss).

Risk stratification The WBC rise from 8.9 to 13.4 on POD2 is the detail that demands attention. A mild leukocytosis is expected post-operatively, but a 50% increase from baseline warrants active monitoring rather than reassurance. The absence of fever and peritonism is reassuring but does not exclude early anastomotic compromise — presentation can be subtle at this stage.

Immediate steps - Ensure adequate IV access and fluid balance documentation; correct any deficit - Hold oral intake at sips for now — do not advance diet - Obtain CRP urgently if not already resulted; a CRP >150 on POD3–4 has reasonable sensitivity for anastomotic leak in colorectal surgery - Ensure a baseline lactate is available; order if not done - Examine the wound and drain output carefully — character, volume, any feculent or turbid output significantly raises leak probability - Review the operative note: anastomotic technique (stapled vs hand-sewn), any intraoperative concerns, drain placement

Monitoring threshold If by POD3: (a) WBC is trending down, (b) CRP is <150 and/or trending as expected, (c) patient passes flatus, (d) remains afebrile with soft abdomen → this is consistent with ileus; advance to clear fluids cautiously.

If by POD3–4 any of the following: fever >38.5°C, rising or persistently elevated WBC, CRP >150, peritonism, drain output becoming turbid/feculent, or clinical deterioration → CT abdomen/pelvis with IV contrast is indicated to evaluate anastomotic integrity and rule out collection.

Do not advance diet or push for early discharge on the basis of an "ileus" diagnosis before the trajectory of inflammatory markers is clear. The WBC rise in an otherwise well-looking patient is the signal to watch, not dismiss.

Communication Brief your attending on the WBC trend today. If the picture is ambiguous by tomorrow morning, a low threshold for CT is appropriate — a missed leak caught on POD4 is a very different problem from one caught on POD7.

Correct answer: B — Ramipril

Explanation: In a patient with type 2 diabetes and CKD, an ACE inhibitor (or ARB) is the preferred first-line antihypertensive agent regardless of the presence or absence of albuminuria in current guidelines (KDIGO 2021, Canadian Diabetes Association). The renoprotective effect of renin-angiotensin system blockade is established in diabetic nephropathy and extends to CKD patients without overt proteinuria in this clinical context.

Why the distractors are incorrect: - A (Amlodipine): A reasonable second-line or combination agent in this population, and appropriate for isolated systolic hypertension without CKD/DM comorbidity, but not preferred as monotherapy first-line here. - C (HCTZ): Thiazide diuretics can worsen glycaemic control and are less nephroprotective in CKD; not first-line in this combination of comorbidities. - D (Metoprolol): Beta-blockers are not first-line for hypertension without compelling indications (post-MI, heart failure with reduced EF, rate control). Can mask hypoglycaemia symptoms in insulin-treated diabetics. - E (Spironolactone): Contraindicated or used with caution in CKD (eGFR <45 threshold in many guidelines) due to hyperkalaemia risk; not appropriate as first-line here.

Key teaching point: In diabetic CKD, ACE inhibitor or ARB is the default first-line antihypertensive choice due to nephroprotection. Monitor eGFR and potassium at 1–2 weeks after initiation.